Literature DB >> 24825771

Chromatin remodeling: from transcription to cancer.

Moshe Yaniv1.   

Abstract

In this short review article, I have tried to trace the path that led my laboratory from the early studies of the structure of papova minichromosomes and transcription control to the investigation of chromatin remodeling complexes of the SWI/SNF family. I discuss briefly the genetic and biochemical studies that lead to the discovery of the SWI/SNF complex in yeast and drosophila and summarize some of the studies on the developmental role of the murine complex. The discovery of the tumor suppressor function of the SNF5/INI1/SMARCB1 gene in humans and the identification of frequent mutations in other subunits of this complex in different human tumors opened a fascinating field of research on this epigenetic regulator. The hope is to better understand tumor development and to develop novel treatments.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SWI/SNF; cell cycle; development; differentiation; tumor suppressor

Mesh:

Substances:

Year:  2014        PMID: 24825771     DOI: 10.1016/j.cancergen.2014.03.006

Source DB:  PubMed          Journal:  Cancer Genet


  30 in total

Review 1.  SWI/SNF chromatin remodeling complexes and cancer.

Authors:  Jaclyn A Biegel; Tracy M Busse; Bernard E Weissman
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-08-28       Impact factor: 3.908

2.  Schwannomatosis patient who was followed up for fifteen years: A case report.

Authors:  Kai Li; Si-Jing Liu; Huai-Bo Wang; Chang-Yu Yin; Yong-Sheng Huang; Wei-Tao Guo
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

3.  Evaluation of the role of downregulation of SNF5/INI1 core subunit of SWI/SNF complex in clear cell renal cell carcinoma development.

Authors:  Elzbieta Sarnowska; Michal Szymanski; Nataliia Rusetska; Marcin Ligaj; Iga Jancewicz; Pawel Cwiek; Marta Skrodzka; Marcin Leszczynski; Joanna Szarkowska; Alicja Chrzan; Malgorzata Stachowiak; Jaroslaw Steciuk; Anna Maassen; Lech Galek; Tomasz Demkow; Janusz A Siedlecki; Tomasz J Sarnowski
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

4.  Analyses of Epigenetic Modification in Environmental Pollutants-Induced Neurotoxicity.

Authors:  Guangxia Yu; Zhenkun Guo; Huangyuan Li
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Endocrine disruptor induction of epigenetic transgenerational inheritance of disease.

Authors:  Michael K Skinner
Journal:  Mol Cell Endocrinol       Date:  2014-07-31       Impact factor: 4.102

Review 6.  Gene mutations in gastric cancer: a review of recent next-generation sequencing studies.

Authors:  Y Lin; Z Wu; W Guo; J Li
Journal:  Tumour Biol       Date:  2015-09-12

7.  Brahma is required for cell cycle arrest and late muscle gene expression during skeletal myogenesis.

Authors:  Sonia Albini; Paula Coutinho Toto; Alessandra Dall'Agnese; Barbora Malecova; Carlo Cenciarelli; Armando Felsani; Maurizia Caruso; Scott J Bultman; Pier Lorenzo Puri
Journal:  EMBO Rep       Date:  2015-07-01       Impact factor: 8.807

8.  Fgf and Esrrb integrate epigenetic and transcriptional networks that regulate self-renewal of trophoblast stem cells.

Authors:  Paulina A Latos; Angela Goncalves; David Oxley; Hisham Mohammed; Ernest Turro; Myriam Hemberger
Journal:  Nat Commun       Date:  2015-07-24       Impact factor: 17.694

9.  A Single-Nucleotide Polymorphism in the Promoter of Porcine ARHGAP24 Gene Regulates Aggressive Behavior of Weaned Pigs After Mixing by Affecting the Binding of Transcription Factor p53.

Authors:  Qinglei Xu; Jing Zhao; Yanli Guo; Mingzheng Liu; Allan P Schinckel; Bo Zhou
Journal:  Front Cell Dev Biol       Date:  2022-04-01

10.  Genome-Wide Locations of Potential Epimutations Associated with Environmentally Induced Epigenetic Transgenerational Inheritance of Disease Using a Sequential Machine Learning Prediction Approach.

Authors:  M Muksitul Haque; Lawrence B Holder; Michael K Skinner
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.